SCHEMBL808246

SCHEMBL808246

CC1(C)OB(c2cccc(-c3ccccn3)c2)OC1(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.49
LPL P06858 6/20 0.49
CYP2A6 P11509 1/20 0.42
DGAT1 O75907 1/20 0.41
GRM5 P41594 3/20 0.39
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
TLR4 O00206 1/20 0.38
TLR2 O60603 1/20 0.38
BACE1 P56817 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
CCR1 P32246 2/20 0.37
CCR5 P51681 2/20 0.37
CCR8 P51685 2/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
METAP1 P53582 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31134246 1.00 LIPG (0.49) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL30919897 1.00 LIPG (0.49) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL31264392 0.88 LPL (0.41) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL28691368 0.88 LPL (0.41) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL19544227 0.88 LPL (0.47) LIPGLPLCYP2A6DGAT1KDM4E
SCHEMBL31393377 0.88 LIPG (0.44) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL29342374 0.88 LIPG (0.44) LIPGLPLCYP2A6DGAT1GRM5
SCHEMBL17714947 0.88 KDM4E (0.46) LIPGLPLGRM5KDM4ELMNA
SCHEMBL9960104 0.86 LIPG (0.54) LIPGLPLCYP2A6DGAT1KDM4E
SCHEMBL20598797 0.85 LIPG (0.53) LIPGLPLDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618755-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2025-09-24 EP disclosed
EP-4349814-B1 IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME MITSUBISHI CHEM CORP (JP) 2025-07-09 EP disclosed
US-12201015-B2 Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device MITSUBISHI CHEMICAL CORPORATION (JP) 2025-01-14 US disclosed
CN-119054438-A Composition for light-emitting layer, organic electroluminescent element, and method for producing same 三菱化学株式会社 2024-11-29 CN disclosed
US-12127470-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-10-22 US disclosed
WO-2024203548-A1 IRIDIUM COMPLEX COMPOUND, COMPOSITION, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT 三菱ケミカル株式会社 2024-10-03 WO disclosed
WO-2024162247-A1 ORGANOMETALLIC COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE キヤノン株式会社 2024-08-08 WO disclosed
WO-2024107746-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES (US) 2024-05-23 WO disclosed
US-20240147833-A1 Iridium Complex Compound, Iridium Complex Compound-Containing Composition, Organic Electroluminescent Element, and Method for Manufacturing the Same MITSUBISHI CHEMICAL CORPORATION (JP) 2024-05-02 US disclosed
EP-4349814-A1 IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2024-04-10 EP disclosed
US-20110227049-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-22 US disclosed
US-20110227049-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-22 US disclosed
EP-2342305-A1 PHOSPHORESCENT MATERIALS Universal Display Corporation (US) 2011-07-13 EP disclosed
WO-2011070990-A1 NEW IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2011-06-16 WO disclosed
US-20110042654-A1 Organic compound, and organic photoelectric device comprising the same CHEIL INDUSTRIES, INC. (KR) 2011-02-24 US disclosed
US-20110042654-A1 Organic compound, and organic photoelectric device comprising the same CHEIL INDUSTRIES, INC. (KR) 2011-02-24 US disclosed
WO-2010028151-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 WO disclosed
WO-2010027583-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 WO disclosed
WO-2010027583-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 WO disclosed
WO-2010028151-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12201015-B2 Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device INF2, EMC2, INTS9 LIPG 4251/4885LPL 4208/4885CYP2A6 2054/4885
US-20110042654-A1 Organic compound, and organic photoelectric device comprising the same PPOX, OR10J3, OCIAD1 LIPG 3360/4885LPL 3617/4885CYP2A6 1134/4885
US-12127470-B2 Organic electroluminescent materials and devices SOD1, CLTB, L1CAM LIPG 3545/4885LPL 3973/4885CYP2A6 2637/4885
US-20110227049-A1 PHOSPHORESCENT MATERIALS PPIP5K2, PAICS, IP6K1 LIPG 4758/4885LPL 4256/4885CYP2A6 2502/4885
US-20240147833-A1 Iridium Complex Compound, Iridium Complex Compound-Containing Composition, Organic Electroluminescent Element, and Method for Manufacturing the Same INTS9, IGF1R, INF2 LIPG 3726/4885LPL 2515/4885CYP2A6 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.